- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07708701
Brochure-Supported Telemedicine Management of Postdural Puncture Headache (Brochure-Suppo)
The Effect of Brochure-Supported Structured Telemedicine Counseling on the Management of Postdural Puncture Headache After Cesarean Delivery Under Spinal Anesthesia: A Prospective Randomized Trial
Study Overview
Status
Conditions
Detailed Description
Postdural puncture headache may occur during the first few days after spinal anesthesia and may become apparent after hospital discharge. During this period, patients need to recognize headache characteristics, follow conservative treatment recommendations, and identify symptoms that require medical evaluation.
This prospective, randomized, open-label study included women aged 18-49 years undergoing elective cesarean delivery under spinal anesthesia. Participants were randomly assigned to one of two parallel groups.
The standard-care group received routine verbal information regarding spinal anesthesia, possible complications, and post-discharge precautions, together with standard telephone follow-up.
The intervention group received the same standard information plus a visual brochure entitled "Five Golden Points After Spinal Anesthesia." The brochure provided information about postdural puncture headache symptoms, positional characteristics, conservative measures that could be used at home, warning symptoms requiring medical attention, and relevant contact information. Structured telemedicine counseling reinforced the brochure content, repeated conservative treatment recommendations, answered patient questions, and provided guidance regarding warning symptoms.
Telephone follow-up was performed on days 1, 2, 3, 4, and 5 after discharge. During follow-up, the presence of postdural puncture headache, pain severity measured using the Numerical Rating Scale, associated symptoms, adherence to conservative treatment recommendations, and hospital re-presentation were evaluated. For participants whose headache continued beyond day 5, total headache duration was recorded until complete symptom resolution.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Van
-
Van, Van, Turkey (Türkiye), 65040
- Van Yuzuncu Yil University Dursun Odabas Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pregnant women aged 18-49 years
- American Society of Anesthesiologists physical status II or III
- Scheduled for elective cesarean delivery under spinal anesthesia
- Available for telephone follow-up after hospital discharge
- Provided written informed consent
Exclusion Criteria:
- Conversion to or performance of general anesthesia
- Diagnosis of panic disorder or depression
- Hypertension
- Circulatory or coagulation disorders
- Placental abnormalities
- Requirement for perioperative blood transfusion
- Inability to be contacted during the follow-up period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard information and standard telephone follow-up
Participants received routine verbal information before and after surgery regarding spinal anesthesia, possible complications, and post-discharge precautions.
Standard telephone follow-up was conducted on days 1, 2, 3, 4, and 5 after discharge to assess the presence of postdural puncture headache, pain severity, and adherence to conservative treatment recommendations.
|
Routine verbal information regarding spinal anesthesia, possible complications, and post-discharge precautions was provided before and after surgery.
Standard telephone follow-up was conducted on days 1 through 5 after discharge to assess postdural puncture headache, pain severity, associated symptoms, and adherence to conservative treatment recommendations.
|
|
Experimental: Brochure-Supported Structured Telemedicine Counseling
Participants received routine verbal information and standard follow-up, together with a visual information brochure within the first 12 postoperative hours.
Structured telemedicine counseling was provided on days 1, 2, 3, 4, and 5 after discharge to reinforce the brochure content, repeat conservative treatment recommendations, answer patient questions, and provide guidance regarding warning symptoms.
|
Routine verbal information regarding spinal anesthesia, possible complications, and post-discharge precautions was provided before and after surgery.
Standard telephone follow-up was conducted on days 1 through 5 after discharge to assess postdural puncture headache, pain severity, associated symptoms, and adherence to conservative treatment recommendations.
A visual information brochure entitled "Five Golden Points After Spinal Anesthesia" was introduced within the first 12 postoperative hours.
During structured telephone consultations on days 1 through 5 after discharge, the brochure content was reinforced, conservative treatment recommendations were repeated, patient questions were answered, and guidance regarding warning symptoms and appropriate healthcare use was provided.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Severity Among Participants Who Develop Postdural Puncture Headache
Time Frame: 24, 48, 72, 96, and 120 hours after discharge
|
Pain severity is assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Higher scores indicate greater pain severity.
NRS scores are recorded at each follow-up time point among participants who develop postdural puncture headache.
For participants whose headache has resolved, the NRS score is recorded as 0.
|
24, 48, 72, 96, and 120 hours after discharge
|
|
Total Duration of Postdural Puncture Headache
Time Frame: From headache onset until complete symptom resolution, up to 9 days after discharge
|
Total headache duration is defined as the number of days from the onset of postdural puncture headache until complete symptom resolution among participants who develop postdural puncture headache.
If headache persists beyond the fifth follow-up day, duration is determined through additional telephone contact or participant self-report until complete resolution.
|
From headache onset until complete symptom resolution, up to 9 days after discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Postdural Puncture Headache
Time Frame: Within 5 days after discharge
|
The number and percentage of randomized participants who develop postdural puncture headache.
Postdural puncture headache is defined as a frontal or occipital headache that worsens in the upright position and improves when lying down, in accordance with International Headache Society criteria.
|
Within 5 days after discharge
|
|
Adherence to Conservative Treatment Recommendations
Time Frame: 24, 48, 72, 96, and 120 hours after discharge
|
The number and percentage of participants who report adherence to the recommended conservative management plan during standardized telephone follow-up.
Adherence is assessed separately at each follow-up time point.
|
24, 48, 72, 96, and 120 hours after discharge
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Gunter RL, Chouinard S, Fernandes-Taylor S, Wiseman JT, Clarkson S, Bennett K, Greenberg CC, Kent KC. Current Use of Telemedicine for Post-Discharge Surgical Care: A Systematic Review. J Am Coll Surg. 2016 May;222(5):915-27. doi: 10.1016/j.jamcollsurg.2016.01.062. Epub 2016 Feb 13. No abstract available.
- Patel R, Urits I, Orhurhu V, Orhurhu MS, Peck J, Ohuabunwa E, Sikorski A, Mehrabani A, Manchikanti L, Kaye AD, Kaye RJ, Helmstetter JA, Viswanath O. A Comprehensive Update on the Treatment and Management of Postdural Puncture Headache. Curr Pain Headache Rep. 2020 Apr 22;24(6):24. doi: 10.1007/s11916-020-00860-0.
- American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 209: Obstetric Analgesia and Anesthesia. Obstet Gynecol. 2019 Mar;133(3):e208-e225. doi: 10.1097/AOG.0000000000003132.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025/04-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment Adherence and Compliance
-
The University of Texas Health Science Center at...RecruitingTreatment AdherenceUnited States
-
Virginia Commonwealth UniversityRecruitingTreatment AdherenceUnited States
-
University College, LondonNot yet recruitingTreatment Adherence and Compliance
-
University of GiessenKruse Johannes; Florian Blachutzik; Andreas RiethNot yet recruitingHeart Failure | Adherence, Medication | Adherence, Treatment
-
University of MichiganCompletedPhysical Inactivity | Adherence, TreatmentUnited States
-
Cerina TherapeuticsUniversity of Ulster; European CommissionRecruitingTreatment Adherence | Treatment Adherence and Compliance | Generalized AnxietyUnited Kingdom
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingMedication Adherence | Medication ComplianceUnited States
-
Washington University School of MedicineCompleted
-
University of PadovaUniversity of Turin, ItalyNot yet recruiting
-
CNGE ConseilCompleted
Clinical Trials on Standard Information and Standard Telephone Follow-up
-
Hospital Israelita Albert EinsteinNot yet recruitingEmergency Department Overcrowding
-
Sport Injury Prevention Research CentreGeneral Electric; National Basketball AssociationCompletedTendinopathy | Sports Injuries in Children | Injury, Knee | Injury, AnkleCanada
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Trialbureau... and other collaboratorsRecruitingAdolescent Idiopathic ScoliosisNetherlands
-
University Hospital, Basel, SwitzerlandRecruitingThoracic Surgery | Post Operative Recovery | Mobile Health | Follow-upSwitzerland
-
Institut Claudius RegaudCompleted
-
M.D. Anderson Cancer CenterPatient-Centered Outcomes Research InstituteCompletedSmoking Cessation | Lung Cancer | Tobacco Use CessationUnited States
-
bioAffinity Technologies Inc.Precision Pathology Laboratory Services (PPLS); HiRO (Harvest Integrated Research...RecruitingLung Cancer (Diagnosis)United States
-
Aalborg University HospitalRecruiting
-
Massachusetts General HospitalBrigham and Women's HospitalNot yet recruitingHIV Pre-exposure Prophylaxis UseUnited States
-
Sociedad Española de Neumología y Cirugía TorácicaResMed; Asociacio Lleidatana de RespiratoriCompletedSleep Apnea SyndromeSpain